Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radioligand”

157 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 157 results

Early research (Phase 1)Active Not RecruitingNCT05739942
What this trial is testing

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

Who this might be right for
Newly Diagnosed and Recurrent Glioblastoma
Novartis Pharmaceuticals 42
Early research (Phase 1)Looking for participantsNCT07621692
What this trial is testing

Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
National Taiwan University Hospital 12
Early research (Phase 1)Active Not RecruitingNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 13
Large-scale testing (Phase 3)Looking for participantsNCT06855277
What this trial is testing

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 940
Very early researchStudy completedNCT03080051
What this trial is testing

Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

Who this might be right for
Progressive Supranuclear PalsyAlzheimer DiseaseHealthy Volunteers
Molecular NeuroImaging 6
Early research (Phase 1)Active Not RecruitingNCT05870579
What this trial is testing

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 28
Very early researchLooking for participantsNCT06634628
What this trial is testing

IMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009

Who this might be right for
Huntington DiseaseHDPET Tracer+6 more
CHDI Foundation, Inc. 27
Very early researchStudy completedNCT06223971
What this trial is testing

Long COVID-19 [11C]CPPC Study

Who this might be right for
COVID Long-Haul
Johns Hopkins University 6
Early research (Phase 1)Study completedNCT06641219
What this trial is testing

Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen

Who this might be right for
Prostate Cancers
Tomsk National Research Medical Center of the Russian Academy of Sciences 7
Testing effectiveness (Phase 2)Looking for participantsNCT06955169
What this trial is testing

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Who this might be right for
Intracranial Meningioma
RTOG Foundation, Inc. 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04663997
What this trial is testing

177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

Who this might be right for
Prostate Cancer
Canadian Cancer Trials Group 200
Not applicableStudy completedNCT06830408
What this trial is testing

Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study

Who this might be right for
mCRPC
University Hospital, Basel, Switzerland 250
Testing effectiveness (Phase 2)Ended earlyNCT01428505
What this trial is testing

[18F]PBR111 and Microglial Activation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
GlaxoSmithKline 50
Early research (Phase 1)Active Not RecruitingNCT06229366
What this trial is testing

[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerOligometastatic Prostate Carcinoma+1 more
Eli Lilly and Company 142
Early research (Phase 1)Study completedNCT05292040
What this trial is testing

LY3857210 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 10
Very early researchLooking for participantsNCT07798778
What this trial is testing

Clinical Evaluation of SRT-017 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Affiliated Hospital of Jiangnan University 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178938
What this trial is testing

Platform Trial Assessing Uptake, Safety and Efficacy of Theranostic Agents in Solid Tumors With Active Brain Metastases

Who this might be right for
Solid TumorsHER2-positive Breast Cancer
MedSIR 10
Very early researchLooking for participantsNCT06454955
What this trial is testing

Study on B7-H3 Targeted Affibody Radioligand Probes for PET Imaging of Solid Tumors

Who this might be right for
B7H3CD276 AffibodyPET/CT Imaing
Peking University Cancer Hospital & Institute 50
Not applicableStudy completedNCT03324646
What this trial is testing

Evaluation of a Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1)

Who this might be right for
Normal Physiology
National Institute of Mental Health (NIMH) 52
Early research (Phase 1)Looking for participantsNCT07197645
What this trial is testing

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

Who this might be right for
Bone PainMetastatic Bone TumorBone Metastases in Subjects With Advanced Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 33
Next Page